BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer

NCT06085742 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Methotrexate
DRUG: Capecitabine

Sponsor

University of Illinois at Chicago